Mays Cancer Center selected as founding partner of oncology clinical trial diversity alliance

June 23, 2021

Media contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (June 23, 2021) – The Mays Cancer Center, home to UT Health San Antonio MD Anderson, today was announced as a founding partner of the Advancing Inclusive Research® Site Alliance. This coalition of clinical research sites will partner with Genentech, a member of the Roche Group, to […]

Photo of Latino family in hospital room.



Team describes science-based hiccups intervention

June 18, 2021

Users reported relief in 92% of cases. Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (June 18, 2021) — Researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and colleagues worldwide describe a new science-based intervention for hiccups in a research letter published June 18 in the journal JAMA […]

Hiccups relief tool


In JAMA Oncology: Convalescent plasma improves survival in COVID-19 patients with blood cancers

June 17, 2021

(Editor’s note: This story, originally posted on Feb. 11, 2021, has been updated to include the study’s publication in JAMA Oncology on June 17, 2021.) Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (June 17, 2021) — Convalescent plasma therapy was associated with better survival in blood cancer patients hospitalized with COVID-19, especially in sicker patients. […]

Mays Cancer Center, home to UT Health San Antonio MD Anderson


Depression, tau deposits seen in subset of middle-aged persons

June 17, 2021

Framingham Heart Study analysis finds association in APOE ε4 allele carriers. Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (June 17, 2021) — Middle-aged people with depressive symptoms who carry a genetic variation called apolipoprotein (APOE) ε4 may be more at risk to develop tau protein accumulations in the brain’s emotion- and memory-controlling regions, a new […]

man with clinical depression


Novavax vaccine is highly protective against COVID-19 in Phase 3 results

June 14, 2021

Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu Elizabeth Allen, 210-358-2344, elizabeth.allen@uhs-sa.com SAN ANTONIO (June 14, 2021) — Researchers at UT Health San Antonio are buoyed by today’s news that the Novavax vaccine is strongly effective against the COVID-19 virus. Biotechnology company Novavax released Phase 3 clinical trial results from 119 sites in the U.S. and Mexico this […]

Concept photo of injecting vaccine